Emcure Pharmaceuticals Limited

NSEI:EMCURE Stock Report

Market Cap: ₹247.4b

Emcure Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Satish Mehta

Chief executive officer

₹229.6m

Total compensation

CEO salary percentage100.0%
CEO tenure43.3yrs
CEO ownership45.5%
Management average tenure3yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Satish Mehta's remuneration changed compared to Emcure Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024₹230m₹230m

₹5b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹6b

Jun 30 2023n/an/a

₹6b

Mar 31 2023n/an/a

₹5b

Mar 31 2022₹235m₹162m

₹7b

Compensation vs Market: Satish's total compensation ($USD2.74M) is above average for companies of similar size in the Indian market ($USD573.46K).

Compensation vs Earnings: Satish's compensation has been consistent with company performance over the past year.


CEO

Satish Mehta (73 yo)

43.3yrs

Tenure

₹229,590,000

Compensation

Mr. Satish Ramanlal Mehta serves as the Chief Executive Officer and Managing Director at Emcure Pharmaceuticals Ltd and has been its Executive Director since April 16, 1981. Mr. Mehta has a wealth of exper...


Leadership Team

NamePositionTenureCompensationOwnership
Satish Mehta
CEO, MD & Executive Directorno data₹229.59m45.45%
₹ 112.4b
Tajuddin Shaikh
Chief Financial Officer3.3yrs₹17.46mno data
Samit Mehta
President of Operations & Whole-Time Directorno data₹33.53m7.17%
₹ 17.7b
Mukund Gurjar
Chief Scientific Officer & Whole-Time Directorno data₹57.70m0.16%
₹ 386.9m
Sunil Mehta
Executive Director of Projects & Whole-Time Directorno data₹34.45m6.07%
₹ 15.0b
Namita Thapar
Executive Director of India Business & Whole-Time Directorno data₹45.96m3.35%
₹ 8.3b
Chetan Sharma
Company Secretary & Compliance Officer1.1yrsno datano data
Naveen Soni
Director of Corporate Communications & Public Relations3yrsno datano data
Vikas Thapar
President of Corporate Developmentno data₹32.56m0.36%
₹ 883.2m
Rajesh Nair
Executive Vice President of Human Resourcesno datano datano data
Sanjay Mehta
President of Emerging Marketsno data₹30.92m1.98%
₹ 4.9b
Deepak Gondaliya
President of Technical Operationsno data₹21.42mno data

3.0yrs

Average Tenure

52.5yo

Average Age

Experienced Management: EMCURE's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Satish Mehta
CEO, MD & Executive Director43.3yrs₹229.59m45.45%
₹ 112.4b
Samit Mehta
President of Operations & Whole-Time Director2yrs₹33.53m7.17%
₹ 17.7b
Mukund Gurjar
Chief Scientific Officer & Whole-Time Director23yrs₹57.70m0.16%
₹ 386.9m
Sunil Mehta
Executive Director of Projects & Whole-Time Director11.1yrs₹34.45m6.07%
₹ 15.0b
Namita Thapar
Executive Director of India Business & Whole-Time Director10yrs₹45.96m3.35%
₹ 8.3b
Palamadai Jayakumar
Independent Director4yrs₹3.24mno data
Berjis Desai
Independent Chairman27.3yrs₹10.60m0.10%
₹ 252.3m
Shailesh Ayyangar
Independent Director3.3yrs₹5.32mno data
Samonnoi Banerjee
Non-Executive Director6.5yrs₹520.00kno data
Vidya Yeravdekar
Independent Director3.3yrs₹1.78mno data
Vijay Gokhale
Independent Director3.3yrs₹2.26mno data

6.5yrs

Average Tenure

62yo

Average Age

Experienced Board: EMCURE's board of directors are considered experienced (6.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.